Table 3 The association between IMUP and PAAD clinical pathological features
From: IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
Parameters | IMUP(%) | P Value | |
|---|---|---|---|
− |  +  | ||
Gender | |||
 Male | 46 (45.9%) | 54 (54.1%) | 0.228 |
 Female | 45 (55.0%) | 37 (45.0%) | |
Race | |||
 White | 79 (50.3%) | 78 (40.7%) | 0.670 |
 Black | 3 (50.0%) | 3 (50.0%) | |
 Asia | 4 (36.4%) | 7 (63.6%) | |
Subdivision | |||
 Head of Pancreas | 68 (49.3%) | 70 (50.7%) | 0.448 |
 Body of Pancreas | 6 (42.9%) | 8 (57.1%) | |
 Tail of Pancreas | 7 (46.7%) | 8 (53.3%) | |
Age | |||
 < 60 years | 31 (51.7%) | 29 (48.3%) | 0.749 |
 ≥ 60 years | 60 (49.2%) | 62 (50.8%) | |
Alcohol habit | |||
 No | 43 (55.8%) | 34 (44.2%) | 0.173 |
 Yes | 46 (45.5%) | 55 (54.5%) | |
Grade | |||
 Grade 1 | 0 (0.0%) | 2 (100.0%) | 0.004 |
 Grade 2 | 24 (77.4%) | 7 (22.6%) | |
 Grade 3 | 43 (45.3%) | 52 (54.7%) | |
 Grade 4 | 20 (41.7%) | 28 (58.3%) | |
Stage | |||
 Stage I | 15 (71.4%) | 6 (28.6%) | 0.271 |
 Stage II | 69 (47.3%) | 77 (52.7%) | |
 Stage III | 1 (33.3%) | 2 (66.7%) | |
 Stage IV | 2 (40.0%) | 3 (60.0%) | |
T | |||
 T1 | 6 (66.7%) | 3 (33.3%) | 0.351 |
 T2 | 15 (62.5%) | 9 (37.5%) | |
 T3 | 67 (47.2%) | 75 (52.8%) | |
 T4 | 1 (33.3%) | 2 (66.7%) | |
N | |||
 N0 | 28 (50.9%) | 27 (49.1%) | 0.568 |
 N1 | 61 (49.6%) | 62 (50.4%) | |
M | |||
 M0 | 42 (53.2%) | 37 (46.8%) | 0.749 |
 M1 | 2 (40.0%) | 3 (60.0%) | |